Similar articles for PMID: 22504565

Year	Number of Results
1988	1
1990	1
1993	1
1997	1
1998	1
2002	1
2003	3
2005	3
2006	5
2007	11
2008	8
2009	10
2010	7
2011	16
2012	14
2013	3
2014	6
2015	3
2016	2
2017	4
2018	1
2019	1
2021	1
2022	1
2024	0

1

Is there a sex bias in prescribing anti-tumour necrosis factor medications to patients with rheumatoid arthritis? A nation-wide cross-sectional study.

Arkema EV, Neovius M, Joelsson JK, Simard JF, van Vollenhoven RF. Arkema EV, et al. Ann Rheum Dis. 2012 Jul;71(7):1203-6. doi: 10.1136/annrheumdis-2011-200947. Epub 2012 Apr 13. Ann Rheum Dis. 2012. PMID: 22504565

2

The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug.

Söderlin MK, Petersson IF, Geborek P. Söderlin MK, et al. Scand J Rheumatol. 2012 Feb;41(1):1-9. doi: 10.3109/03009742.2011.599073. Epub 2011 Nov 28. Scand J Rheumatol. 2012. PMID: 22118371

3

Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.

Pease C, Pope JE, Truong D, Bombardier C, Widdifield J, Thorne JC, Paul Haraoui B, Psaradellis E, Sampalis J, Bonner A. Pease C, et al. Semin Arthritis Rheum. 2011 Aug;41(1):81-9. doi: 10.1016/j.semarthrit.2010.09.004. Epub 2010 Dec 17. Semin Arthritis Rheum. 2011. PMID: 21168187

4

Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors.

Iannone F, Gremese E, Atzeni F, Biasi D, Botsios C, Cipriani P, Ferri C, Foschi V, Galeazzi M, Gerli R, Giardina A, Marchesoni A, Salaffi F, Ziglioli T, Lapadula G; Gruppo Italiano di Studio sulle Early Arthritides (GISEA). Iannone F, et al. J Rheumatol. 2012 Jun;39(6):1179-84. doi: 10.3899/jrheum.111125. Epub 2012 Apr 1. J Rheumatol. 2012. PMID: 22467933

5

Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?

Askling J, van Vollenhoven RF, Granath F, Raaschou P, Fored CM, Baecklund E, Dackhammar C, Feltelius N, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Rantapää-Dahlqvist S, Saxne T, Klareskog L. Askling J, et al. Arthritis Rheum. 2009 Nov;60(11):3180-9. doi: 10.1002/art.24941. Arthritis Rheum. 2009. PMID: 19877027 Free article.

6

Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis.

Savioli C, Ribeiro AC, Fabri GM, Calich AL, Carvalho J, Silva CA, Viana VS, Bonfá E, Siqueira JT. Savioli C, et al. J Clin Rheumatol. 2012 Jun;18(4):180-4. doi: 10.1097/RHU.0b013e31825828be. J Clin Rheumatol. 2012. PMID: 22647860

7

Effectiveness of a third tumor necrosis factor-α-blocking agent compared with rituximab after failure of 2 TNF-blocking agents in rheumatoid arthritis.

Blom M, Kievit W, Donders AR, den Broeder AA, Straten VH, Kuper I, Visser H, Jansen TL, Brus HL, Branten AJ, van de Laar MA, van Riel PL. Blom M, et al. J Rheumatol. 2011 Nov;38(11):2355-61. doi: 10.3899/jrheum.101324. Epub 2011 Sep 1. J Rheumatol. 2011. PMID: 21885487

8

Persistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: observations from the RADIUS registry.

Markenson JA, Gibofsky A, Palmer WR, Keystone EC, Schiff MH, Feng J, Baumgartner SW. Markenson JA, et al. J Rheumatol. 2011 Jul;38(7):1273-81. doi: 10.3899/jrheum.101142. Epub 2011 May 15. J Rheumatol. 2011. PMID: 21572150

9

Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.

Dewedar AM, Shalaby MA, Al-Homaid S, Mahfouz AM, Shams OA, Fathy A. Dewedar AM, et al. Int J Rheum Dis. 2012 Jun;15(3):330-5. doi: 10.1111/j.1756-185X.2012.01715.x. Epub 2012 Feb 13. Int J Rheum Dis. 2012. PMID: 22709496

10

B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.

Finckh A, Ciurea A, Brulhart L, Kyburz D, Möller B, Dehler S, Revaz S, Dudler J, Gabay C; Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis. Finckh A, et al. Arthritis Rheum. 2007 May;56(5):1417-23. doi: 10.1002/art.22520. Arthritis Rheum. 2007. PMID: 17469098 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

88 results

Results by year